Profile of Abaloparatide and Its Potential in the Treatment of Postmenopausal Osteoporosis

Abaloparatide (previously known as BA058) is a synthetic 34-amino acid peptide and novel selective activator of parathyroid hormone receptor 1 (PTHR1) currently under development as a new anabolic agent in the management of osteoporosis. This paper reviews the profile and potential of abaloparatide...

Descripción completa

Detalles Bibliográficos
Autores principales: Tella, Sri Harsha, Kommalapati, Anuhya, Correa, Ricardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2017
Materias:
Endocrinology/Diabetes/Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5493470/
https://www.ncbi.nlm.nih.gov/pubmed/28680788
http://dx.doi.org/10.7759/cureus.1300

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5493470/
https://www.ncbi.nlm.nih.gov/pubmed/28680788
http://dx.doi.org/10.7759/cureus.1300

Ejemplares similares